Biopsy: What It Is, Types, What It Can and Cannot Tell You

Key takeaways

• A biopsy examines tissue, not the whole organ, sampling error is a real limitation.
• Biopsy technique varies widely, from a needle prick under local anaesthetic to a surgical procedure under general anaesthesia, and the risks differ accordingly.
• "No malignancy identified" means cancer was not seen in the sample taken; it does not always mean cancer is absent.
• Preparation, fasting and blood-thinner instructions are decided by the team performing the procedure and by your prescriber, never stop a prescribed medicine on your own.
• Only the doctor who requested the biopsy can interpret the pathology report in the context of your symptoms, imaging and other tests.

At a glance

Also known as

• Biopsy test, tissue test
• Histopathology or HPE (histopathological examination), the laboratory test done on the tissue
• FNAC (fine needle aspiration cytology), often called a "needle test"
• Core biopsy, trucut biopsy
• Bone marrow test for bone marrow aspiration and trephine biopsy
• In Indian clinics you may hear "tissue bheja hai", "sample for biopsy", or the lesion being "sent for HPE"

What a biopsy is

A biopsy has two parts. The first is the procedure that obtains the sample. The second is the laboratory examination of that sample, which is where the diagnosis actually comes from.

In the laboratory, tissue is processed, thinly sectioned, stained and read under a microscope. Depending on the clinical question, the pathologist may add special stains, immunohistochemistry, cultures for tuberculosis or fungi, flow cytometry, or molecular and genetic tests. These add-on tests extend the time needed before a final report can be issued.

A related but distinct approach is cytology, where individual cells rather than intact tissue architecture are examined, for example FNAC of a thyroid nodule or lymph node, or a Pap smear. Cytology is quicker and less invasive but gives less information about tissue architecture, and often cannot grade a tumour or assess invasion.

Why a biopsy is done

• To confirm or exclude cancer in a specific lesion and to determine its type, grade and, where relevant, receptor or molecular status that guides treatment.
• To diagnose infection: tissue can be sent for tuberculosis testing (including culture and nucleic acid amplification), fungal stains and other microbiology when imaging alone cannot distinguish infection from malignancy.
• To characterise inflammatory and immune-mediated disease: for example kidney biopsy in glomerular disease, skin biopsy in blistering disorders, or intestinal biopsy in coeliac disease and inflammatory bowel disease.
• To assess organ damage: liver biopsy can assess inflammation and fibrosis; kidney biopsy can assess scarring and activity.
• To monitor transplant rejection, treatment response, or change in a known disease.

Who should consider a biopsy

A biopsy is advised by a doctor, not chosen by a patient, and is usually considered when:

• Imaging or examination has found a lump, mass or abnormal area that cannot be confidently characterised without tissue.
• A persistent lymph node enlargement has not settled and tuberculosis, lymphoma or metastatic disease is being considered.
• A skin lesion is changing, non-healing, pigmented and irregular, or a rash is undiagnosed after treatment trials.
• Blood tests suggest a marrow, liver or kidney disorder where the pattern of disease cannot be determined non-invasively.
• Cancer treatment decisions require tumour typing or molecular markers.
• A previously treated cancer may have recurred and confirmation is needed.

A biopsy may be deferred or avoided when a lesion is confidently benign on imaging, when the result would not change management, or when bleeding risk, sedation risk or lesion location makes the procedure unsafe. A surgeon may also proceed directly to removing a lesion rather than biopsying it first.

What a biopsy cannot detect or exclude

• Disease outside the sampled area. A biopsy reports on the tissue in the container. If the needle missed the abnormal focus, the report can be normal while disease is present. This is called sampling error and is more likely with small, deep, patchy or necrotic lesions.
• The full extent or stage of a cancer. Staging needs imaging, and sometimes surgery or nodal sampling. A biopsy alone does not tell you whether a cancer has spread.
• Whether a lesion will behave aggressively. Grade and molecular markers give probabilities, not certainties.
• Every infection. Tuberculosis, in particular, can show non-specific inflammation without the classic granulomas, and cultures can be negative despite active infection.
• Function. A liver or kidney biopsy shows structure and injury pattern; blood tests and functional studies are still needed to assess how the organ is working.
• Adequacy is not guaranteed. Some samples come back as inadequate, insufficient or non-diagnostic, and a repeat procedure or a different technique may be required.

A report stating "no malignant cells identified" describes what was seen. It is not the same as cancer being ruled out. If symptoms persist, a lump grows, or new problems appear despite a reassuring biopsy report, return to your doctor.

Related but different examinations

Which comes first depends on the clinical problem

There is no universal order of tests. What comes first depends on what is being asked:

• Breast lump: clinical examination and imaging usually precede biopsy, and image-guided core biopsy is commonly preferred over FNAC when a tissue diagnosis and receptor status are needed.
• Enlarged neck node in India: FNAC is often the first step because it can point towards tuberculosis, reactive change or malignancy quickly; excision biopsy follows when lymphoma is suspected or FNAC is inconclusive.
• Suspicious skin lesion: punch, shave or excision biopsy is usually the first definitive step.
• Abnormal liver tests: blood tests, viral serology, imaging and non-invasive fibrosis assessment usually come before biopsy, which is reserved for unresolved cases.
• Unexplained anaemia or abnormal blood counts: peripheral smear and blood tests come first; bone marrow examination follows if the cause remains unclear.

How to prepare

Preparation is specific to the type of biopsy, the site, the anaesthesia planned and the unit performing it. Written instructions from your own team take precedence over anything on this page.

• Share your full medical history: medicines, herbal or AYUSH products, gym supplements, allergies (including to local anaesthetic, iodine or adhesive), previous bleeding problems and pregnancy status.
• Blood-thinning medicines: aspirin, clopidogrel, warfarin, acenocoumarol and newer oral anticoagulants may need to be timed differently around the procedure. This decision belongs to the prescriber and the doctor performing the biopsy. Do not stop, restart or alter any of these on your own.
• Blood tests: many units check haemoglobin, platelet count and clotting before deeper biopsies.
• Fasting: required for sedation or general anaesthesia and for most endoscopic biopsies; often not required for a skin or superficial needle biopsy. Follow the fasting window your unit gives you.
• Escort and transport: arrange someone to accompany you home if sedation or anaesthesia is planned. Do not drive yourself.
• Clothing and jewellery: you may be asked to change and to remove ornaments near the site.

If you have diabetes on glucose-lowering treatment

Fasting for a biopsy can cause low blood sugar if insulin or certain tablets are taken as usual. Ask your prescriber in advance how to time your doses on the day, and tell the unit that you have diabetes so you can be scheduled and monitored appropriately.

If you have chronic kidney disease

Contrast-guided procedures, sedation doses and bleeding risk all need review in kidney disease. If you are on dialysis, the timing of the biopsy relative to dialysis and heparin use must be planned by the team.

If you have heart failure or are on a fluid restriction

Lying flat for a prolonged period may be uncomfortable or unsafe, and pre-procedure fluid instructions must respect your restriction. Tell the team before the appointment so positioning and fluids can be adjusted.

If you are pregnant or may be pregnant

Tell the team before any biopsy. Many biopsies can be performed safely in pregnancy, but the choice of imaging guidance, anaesthesia and drugs changes. CT guidance and certain sedative agents are usually avoided or modified. Ultrasound guidance in pregnancy is subject to India's PC-PNDT Act 1994, which prohibits any use of ultrasound for sex determination of a foetus.

Children

Paediatric biopsies are often done under sedation or general anaesthesia with weight-based dosing and paediatric fasting rules, which differ from adult rules. Age-appropriate explanation and a parent's presence where allowed reduce distress.

Older adults

Multiple medicines, frailty, cognitive change and slower wound healing all affect planning. Sedation is titrated more cautiously, and someone should be available at home afterwards.

What happens during a biopsy

• Consent and check-in: the doctor explains the procedure, alternatives and risks, and confirms the site, side and your identity.
• Positioning and cleaning: the skin is cleaned with antiseptic and the area draped.
• Anaesthesia: local anaesthetic is injected for most needle and skin biopsies, the injection stings briefly, then the area becomes numb. Sedation or general anaesthesia is used for endoscopic, deep or surgical biopsies.
• Sampling: the needle or instrument is guided to the target, sometimes with ultrasound or CT. Core biopsies often make a clicking sound. Several passes may be needed for an adequate sample.
• Pressure and dressing: the site is compressed and dressed; stitches are used after some surgical and skin biopsies.
• Observation: superficial biopsies often need only a short wait. Liver, kidney, lung and marrow biopsies usually need a few hours of monitoring, and some require overnight stay.

How long does it take

• FNAC or skin punch biopsy: usually a few minutes of actual sampling.
• Image-guided core biopsy: commonly 15-45 minutes including positioning and imaging.
• Endoscopic biopsy: the biopsy itself takes moments; the endoscopy around it takes longer.
• Bone marrow aspiration and trephine: typically around 20-30 minutes.
• Surgical or excision biopsy: often 30-60 minutes or more, plus anaesthesia and recovery time.

Add time for registration, consent, pre-procedure checks and post-procedure observation, so the total hospital visit is considerably longer than the procedure. Reporting time depends on the tissue, the fixation and processing required, and whether special stains, immunohistochemistry, cultures or molecular tests are added, your unit will tell you when to expect the report.

Aftercare and recovery

• Superficial needle and skin biopsies: most people return to routine activity the same or next day. Keep the dressing dry as advised.
• Deeper and surgical biopsies: rest, avoiding heavy lifting or strenuous exercise for the period your team specifies, and wound care instructions apply.
• Pain: mild soreness and bruising are common. Ask your doctor which pain reliever is appropriate for you, particularly if you have kidney disease, ulcer disease, or are on blood thinners.
• Stitch removal or review: attend the follow-up appointment even if you feel well, because that is usually when the report is discussed.

Recovery varies depending on individual clinical circumstances.

Understanding your biopsy report

A pathology report is descriptive, not a treatment plan. Common elements include the site and type of specimen, a gross description, a microscopic description, and a final diagnosis or impression. Cancer reports may add tumour type, grade, margins, lymphovascular invasion, node status and marker results.

There is no "normal range" for a biopsy. Reports are usually framed as:

• Benign / no malignancy identified: no cancer was seen in the tissue examined. Interpretation depends on whether the sample came from the right place and was adequate.
• Malignant: cancer cells were identified, usually with a type and grade.
• Atypical, suspicious or indeterminate: features are abnormal but not diagnostic. Repeat sampling, a larger biopsy, additional stains or expert review may be advised.
• Inflammatory or infective pattern: for example granulomatous inflammation, which in India raises the possibility of tuberculosis but is not specific to it.
• Inadequate or non-diagnostic: the sample could not answer the question.

Do not diagnose yourself from the wording. Terms such as "atypia", "dysplasia", "in situ" and "invasive" have precise meanings that change management significantly. The doctor who requested the biopsy interprets the report alongside your symptoms, examination and imaging.

When biopsy results can be misleading

When a biopsy can falsely suggest no disease (false negative)

• Sampling error: the needle missed the abnormal focus, especially in small, deep, mobile or patchy lesions.
• Necrotic or fibrotic tissue: the sample contains dead or scarred tissue rather than viable diagnostic tissue.
• Too little tissue: insufficient material for stains or molecular tests.
• Prior treatment: antibiotics, anti-tubercular therapy, steroids, chemotherapy or radiotherapy can alter or suppress the diagnostic features.
• Culture-negative tuberculosis: tissue may show non-specific inflammation despite active infection.

When a biopsy can falsely suggest disease or overstate it (false positive or over-call)

• Reactive and healing changes: regenerating tissue, recent surgery, ulceration or infection can mimic atypia.
• Radiation or chemotherapy effect: treated tissue can look alarming under the microscope.
• Crush or handling artefact: squeezed, poorly fixed or delayed-fixation samples can distort cells.
• Borderline lesions: some entities sit genuinely on a spectrum and two pathologists may grade them differently. A second opinion on the slides or blocks is a legitimate step.

Grading and some diagnostic categories involve expert judgement and have known inter-observer variation. A grade is not a fixed, mathematical measurement, and patients often read more into a number than is intended.

Risks and safety by type of biopsy

Risk depends heavily on which biopsy is done, where, and on your own health. A single safety statement cannot cover the whole family of procedures. Ask your doctor for the risks specific to your planned biopsy.

Superficial needle biopsy and FNAC

Generally low risk. Bruising, brief pain, small haematoma and, uncommonly, infection or fainting. Bleeding risk is higher if you are on anticoagulants or have a low platelet count.

Skin biopsy

Bleeding, infection and a permanent scar or pigment change at the site. Keloid formation is more common in some individuals.

Liver biopsy

Pain at the site or shoulder tip is common. Significant bleeding is uncommon but can be serious, and rarely injury to the gallbladder, lung or bowel occurs. Higher risk with coagulopathy, ascites or vascular lesions.

Kidney biopsy

Blood in urine and bruising around the kidney are recognised outcomes; significant bleeding requiring transfusion or intervention is uncommon. Uncontrolled hypertension and clotting problems increase risk.

Lung and mediastinal biopsy

Air leak into the chest cavity (pneumothorax), sometimes requiring a chest drain, and coughing up small amounts of blood. Risk is higher with emphysema or a small deep lesion.

Bone marrow aspiration and trephine

Pain during aspiration is usual and short-lived. Bleeding and local infection are uncommon.

Endoscopic biopsy

Risks mostly relate to the endoscopy itself, bleeding, perforation (uncommon), and sedation-related breathing or blood-pressure effects.

Surgical and excision biopsy

Wound infection, bleeding, scarring, numbness near the site, and anaesthesia-related risks.

Biopsy in the Indian context

• Tuberculosis is a leading differential. In India, an enlarged lymph node, a lung nodule, a bone lesion or bowel thickening can be tuberculosis rather than cancer. Tissue is therefore often sent both for histopathology and for TB testing. Granulomatous inflammation on a report is suggestive but not conclusive, and TB culture can take weeks.
• Anti-tubercular therapy and drug-induced liver injury. Anti-TB drugs are a common cause of liver injury in India. Herbal, AYUSH and gym or bodybuilding supplements are also recognised causes. Disclose everything you take, including products bought without prescription, when a liver biopsy or liver evaluation is planned.
• Anaemia and haemoglobin disorders. Iron-deficiency anaemia is widespread, and thalassaemia trait and other haemoglobinopathies are common in several Indian populations. These influence pre-procedure assessment and sometimes the interpretation of blood findings that prompted a marrow examination.
• Ultrasound-guided procedures and the law. Any ultrasound use in India is governed by the PC-PNDT Act 1994, which makes prenatal sex determination illegal. Registered facilities display this notice.
• Data privacy. Pathology reports are sensitive personal health data. Handling of your information by hospitals and online portals in India is governed by the Digital Personal Data Protection Act 2023.
• Second opinions on slides. Slides and paraffin blocks belong to your case record and can usually be released for expert review at another centre. Ask the pathology department about the process before you travel.
• Advertising claims. Under the Drugs and Magic Remedies (Objectionable Advertisements) Act 1954, claims of guaranteed cancer cures or "painless guaranteed diagnosis" are not permissible. Treat such claims with caution.

Cost and insurance in India

Biopsy costs vary widely across the country and cannot be reduced to a single figure. Costs are usually split between the procedure and the laboratory testing.

• Type and site: a skin punch or FNAC costs far less than a CT-guided lung biopsy or a theatre-based excision biopsy.
• Imaging guidance: ultrasound, CT, MRI or stereotactic guidance each add cost.
• Anaesthesia and stay: sedation, general anaesthesia, day-care or overnight observation add significantly.
• Laboratory add-ons: routine histopathology is the base charge; immunohistochemistry panels, special stains, TB cultures, flow cytometry and molecular or genetic testing are billed separately and can exceed the cost of the procedure.
• Number of blocks and slides processed.
• Setting: government, trust, standalone laboratory and corporate hospital pricing differ substantially, as does pricing between metros and smaller cities.
• Insurance: outpatient diagnostic biopsies are often not covered by standard indemnity policies, while biopsies done during a covered admission or day-care procedure frequently are. Pre-authorisation, waiting periods and sub-limits vary by policy. Government schemes such as Ayushman Bharat PM-JAY cover specified packages at empanelled hospitals. Confirm coverage with your insurer or the hospital's insurance desk before the procedure.

Ask for an itemised estimate that separates procedure, anaesthesia, consumables and likely laboratory add-ons, and ask what happens to the cost if repeat sampling or additional tests are required.

Myths and facts

Frequently asked questions

Will I be awake during a biopsy?

For most needle, skin and superficial biopsies you stay awake with the area numbed by local anaesthetic. Endoscopic, deep, paediatric and surgical biopsies commonly use sedation or general anaesthesia. The team decides based on the site, expected duration and your health, and explains this during consent.

What does it mean if my report says the sample was inadequate?

It means the tissue obtained could not answer the clinical question, often too few cells, crushed tissue, or only necrotic material. It is not a result in itself. Your doctor may advise repeat sampling, a larger core, image guidance, or a different approach such as excision biopsy.

Can a biopsy be wrong?

Yes, though modern pathology is highly reliable. Errors arise mainly from sampling the wrong area, inadequate tissue, treatment-altered tissue, or genuinely borderline appearances where experts may differ. If the report does not fit the clinical picture, your doctor can request expert review of the slides or repeat sampling.

Do I need someone to come with me?

Bring someone if sedation or general anaesthesia is planned, because you must not drive afterwards. For a simple skin biopsy or FNAC under local anaesthetic, most people attend alone, but a companion is helpful if you feel anxious or tend to faint during procedures.

Is FNAC enough, or do I need a core biopsy?

It depends on the question. FNAC can often distinguish benign from suspicious cells in thyroid nodules and lymph nodes. A core biopsy gives intact tissue, which is usually needed for tumour typing, grading and marker testing such as hormone receptors. Your doctor selects based on the suspected diagnosis.

Can a biopsy be done during pregnancy?

Many biopsies can be performed during pregnancy when the diagnosis cannot safely wait. Planning changes: CT guidance and some sedative drugs are usually avoided, positioning is adapted, and obstetric input is sought. Tell the team you are or may be pregnant before booking, not on the day.

Will a biopsy leave a scar?

A needle biopsy typically leaves a tiny mark that usually fades. Skin, excision and surgical biopsies leave a visible scar whose size depends on the specimen needed. Scarring, pigment change and keloid tendency vary between individuals, so results vary depending on individual clinical circumstances.

Why are extra tests being added to my biopsy?

Additional stains, immunohistochemistry, cultures or molecular tests are added when the routine sections do not fully answer the question, or when treatment depends on specific markers. These extras improve diagnostic accuracy, lengthen reporting time and add to the cost. Ask which tests have been requested and why.

Should I get a second opinion on my biopsy report?

A second opinion is reasonable for a new cancer diagnosis, a borderline or indeterminate report, or when the report conflicts with your clinical picture. Slides and blocks can usually be released for review. Discuss this with your treating doctor so review happens without unnecessary delay in treatment.

Sources

• World Health Organization, Global Tuberculosis Report (latest edition) and WHO guidance on tuberculosis diagnostics.
• Pre-conception and Pre-natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994, Government of India.
• Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, Government of India.
• Digital Personal Data Protection Act, 2023, Government of India.
• National Medical Commission, professional conduct regulations on consent and disclosure.
• Ayushman Bharat PM-JAY, National Health Au